Medical Imaging Reagents Market Poised for 7 % Growth, Set to Hit $21.31 Billion by 2029

Which drivers are expected to have the greatest impact on the over the medical imaging reagents market's growth?
The escalation in chronic disease frequency is predicted to contribute to the expansion of the medical imaging reagents industry in the coming future. Chronic illnesses are those that persist for a year or more, require continual medical care, and which may deteriorate with time. Medical imaging reagents are crucial for diagnosing and identifying diseases by visualization of organs and damaged systems. For example, in 2022, the American Cancer Society, a volunteer organization based in the US, estimated about 1.9 million fresh cancer diagnoses and approximately 609,360 cancer-related deaths in the US. Additionally, as per IDF Diabetes Atlas Tenth Edition 2021 report released by the International Diabetes Federation-a Belgium-based consortium of national diabetes organizations-around 537 million individuals (ages 20-79) were projected to be diagnosed with diabetes in 2021. By 2030, the number is expected to rise to 643 million, and by 2045, reach 783 million. The surge in chronic diseases incidence is a key catalyst for the growth of the medical imaging reagents sector.

Get Your Medical Imaging Reagents Market Report Here:
https://www.thebusinessresearchcompany.com/report/medical-imaging-reagents-global-market-report

What is the future CAGR of the medical imaging reagents market, and how will it impact industry expansion?
The market for medical imaging reagents has experienced substantial expansion in the previous years. The market value is projected to increase from $15.23 billion in 2024 to $16.31 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. The historical growth phase can be credited to factors such as rising disease prevalence, an expanding elderly population, enlargement of applications, approval from regulatory authorities, and strategic alliances and partnerships.

In the upcoming years, the medical imaging reagents market is projected to witness a noteworthy expansion. The market size is anticipated to increase to $21.31 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. This growth during the forecasted period is likely due to factors such as personalised medicine, an increased emphasis on early disease detection, a growing global prevalence of chronic diseases, the expansion of point-of-care imaging, and the integration of theranostics. In the forecast period, substantial trends to look out for comprise technological advancements, an increase in chronic disease prevalence, the utilisation of diagnostic imaging in personalised medicine, emerging and globally expanding markets, along with numerous partnerships and collaborations.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9917&type=smp

What are the most significant trends transforming the medical imaging reagents market today?
One significant trend emerging in the medical imaging reagents industry is the focus on product innovations. Major firms in the sector are centred on designing innovative solutions to maintain their standing in the market. For example, in March 2023, Aptamer Group PLC, a UK-based manufacturer of medical imaging reagents, introduced a new product named Optimer-Fc. This product is a combination of an Optimer binder and an antibody's Fc domain, allowing various Optimer instruments to be used in IHC applications. Optimer-Fc is capable of substituting primary detecting antibodies in existing workflows. IHC is a procedure used for identifying disease markers like cancer within cells. This breakthrough in opter binders provides life scientists with the opportunity to investigate both new and known disease biomarkers, thanks to the production of a novel reagent suite which aids in improving research, diagnostics, forensics, and enhances detection accuracy and selectivity.

Which key market segments comprise the medical imaging reagents market and drive its revenue growth?
The medical imaging reagents market covered in this report is segmented -

1) By Class: Contrast Reagents, Optical Reagents, Nuclear Reagents
2) By Technology: Nanoparticles, Fluorescent Dyes, Probes Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots
3) By Modality: X-ray, CT Scan, Ultrasound, MRI Scan
4) By Application: Neurological Disorder, Cardiovascular Disorder, Cancer, Gastrointestinal Disorder, Musculoskeletal Disorder, Nephrological Disorder, Other Applications
5) By End User: Biotechnology Companies, Pharmaceutical Companies, Diagnostic Labs

Subsegments:
1) By Contrast Reagents: Iodine-Based Contrast Agents, Barium Sulfate Contrast Agents, Gadolinium-Based Contrast Agents
2) By Optical Reagents: Fluorescent Dyes, Luminescent Agents, Optical Probes
3) By Nuclear Reagents: Radioisotopes, Radiopharmaceuticals

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9917

What regions are at the forefront of medical imaging reagents market expansion?
North America was the largest region in the medical imaging reagents market in 2024. The regions covered in the medical imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the medical imaging reagents market?
Major companies operating in the medical imaging reagents market include General Electric Company, Lantheus Holdings Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA, Siemens AG, PerkinElmer Inc., Cardinal Health Inc., Shimadzu Corporation, Philips Healthcare, SA Laboratoires André Guerbet, Canon Medical Systems Corporation, Fujifilm Healthcare, Guerbet Group, Merck KGaA, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Toshiba Corporation, Hologic Inc., Carestream Health Inc., Curium Pharma, Nordion Inc., IBA Molecular, Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications, Jubilant Life Sciences Limited, Mallinckrodt Pharmaceuticals, Nihon Kohden Corporation, Mindray Medical International Limited, Samsung Medison Co. Ltd., Analogic Corporation

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9917&type=smp

What Is Covered In The Medical Imaging Reagents Global Market Report?

• Market Size Forecast: Examine the medical imaging reagents market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the medical imaging reagents market for a structured understanding.
• Key Players Overview: Analyze major players in the medical imaging reagents market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the medical imaging reagents market.
• Segment Contributions: Evaluate how different segments drive overall growth in the medical imaging reagents market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the medical imaging reagents market.
• Industry Challenges: Identify potential risks and obstacles affecting the medical imaging reagents market.
• Competitive Landscape: Review strategic developments in the medical imaging reagents market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.